Skip to main content
. Author manuscript; available in PMC: 2018 Dec 1.
Published in final edited form as: Neurosci Biobehav Rev. 2017 Feb 21;83:713–720. doi: 10.1016/j.neubiorev.2017.02.021

Figure 1.

Figure 1

According to the ALZHA model, hallucinatory experiences in Alzheimer’s disease mainly occur in patients with trait markers (i.e., difficulties in suppressing intrusive thoughts or memories, neurological deficits, genetic predisposition and/or sensory deficits), who experience, at a given moment, one or more state markers that will trigger the experience (e.g., psychological distress and/or iatrogenic factors).